Brandinium

Trademark search for:

OSTEOVANCE

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2016-11-24 — Application filed
  • 2017-05-11 — Sn assigned for sect 66a appl from ib
  • 2017-05-12 — Application filed
  • 2017-05-12 — Assigned to examiner
  • 2017-05-16 — Application filed
  • 2017-05-16 — Final disposition recorded
  • 2017-05-17 — Office action issued
  • 2017-06-02 — Office action issued
  • 2017-06-02 — Office action issued
  • 2017-06-24 — Office action issued
  • 2017-07-31 — Office action issued
  • 2017-08-22 — Assigned to lie
  • 2017-08-24 — Correspondence received in law office
  • 2017-08-24 — Teas/email correspondence entered
  • 2017-09-06 — Approved for pub - principal register
  • 2017-09-20 — Notification of notice of publication e-mailed
  • 2017-09-22 — Teas revoke/app/change addr of atty/dom rep received
  • 2017-09-22 — Attorney/dom.rep.revoked and/or appointed
  • 2017-10-04 — Notice of start of opposition period created, to be sent to ib
  • 2017-10-04 — Notification of possible opposition sent to ib
  • 2017-10-06 — Teas post publication amendment received
  • 2017-10-10 — Official gazette publication confirmation e-mailed
  • 2017-10-10 — Published for opposition
  • 2017-10-18 — Assigned to petition staff
  • 2017-10-20 — Post publication amendment - entered
  • 2017-10-21 — Notification processed by ib
  • 2017-12-26 — Registered-principal register
  • 2018-03-26 — Final disposition recorded
  • 2018-04-05 — Final disposition recorded
  • 2018-04-05 — Final disposition recorded
  • 2018-05-19 — Final disposition recorded
  • 2022-06-25 — New representative at ib received
  • 2022-12-26 — Courtesy reminder - sec. 71 (6-yr) e-mailed
  • 2023-03-12 — New representative at ib received
  • 2023-07-24 — New representative at ib received
  • 2023-08-07 — Teas revoke/app/change addr of atty/dom rep received
  • 2023-08-07 — Attorney/dom.rep.revoked and/or appointed
  • 2023-08-07 — Teas change of domestic representatives address
  • 2023-08-07 — Teas change of correspondence received
  • 2024-07-12 — Cancelled section 71
  • 2024-07-12 — Final status recorded
  • 2025-03-12 — Total invalidation of reg ext protection created
  • 2025-06-04 — Invalidation processed
  • 2025-06-05 — Total invalidation of reg ext protection sent to ib
  • 2025-06-20 — Total invalidation processed by the ib

Owner Information

Australian Biotechnologies Pty Limited
AU
Australian Biotechnologies Pty Limited
AU
Australian Biotechnologies Pty Limited
AU

Correspondent

Jami A. Gekas Foley & Lardner LLP
321 North Clark Street
Suite 3000
Chicago, IL 60654-4762

Filing Details

Filing Date:
2016-11-24
Status Date:
2024-07-12
Category:
Pharmaceuticals
Filing Year:
2016

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.